Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |

Biopharma Shows 'Good Start to 2020 News Flow'

The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. In a Jan. 16 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) kicked off the year with news ...
Streetwise Reports | January 22, 2020 |

Coverage Initiated on 'Biotech Machine'

The compelling reasons behind those descriptors are explored in a Dawson James Securities report. In an Aug. 26 research note, analyst Jason Kolbert reported that DawsonJames Securities initiated coverage on Fortress Biotech Inc. (FBIO:NASDAQ) with a Buy rating and ...
Streetwise Reports | September 5, 2019 |

Gold’s Seasonal Outlook for Q4

“What is the best predictor of future behavior? Past behavior.” And while this certainly does not always hold, there is a lesson to be learned from this adage for gold investors. Yup, a saying about behavior might be important for the precious metals mark...
Mike McAra | October 23, 2019 |

2021: A Breakout Year for Uranium Investments?

(Image via Anfield Energy Inc.) The Athabasca Basin is perhaps best known as the world’s leading source of high-grade uranium and currently supplies about 20% of the world’s uranium. It is a region in the Canadian Shield that enco...
Stockhouse Editorial | February 26, 2021 |

Building America’s mine to battery to EV supply chain

In 2010 the US Department of Energy’s Critical Materials Strategy included lithium as one of 14 elements expected to play a vital role in America’s clean energy economy. Lithium is also among 23 critical metals President Trump has deemed ...
Richard (Rick) Mills | October 18, 2019 |

Gold Explorer and Developer 'On Track to Repeat Atlantic Gold Success'

Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report. In an Aug. 21 research note, Haywood analyst Mick Carew reported that Velocity Minerals Ltd. (VLC:TSX.V; VLCJF:OTCQB) is "is on track to repeat Atlantic Gold ...
Streetwise Reports | August 30, 2019 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Looking for Gold in Elephant Country

As Newrange Gold shifts its focus to Nevada, it is monetizing its Colombian properties to fund exploration. Newrange Gold Corp.'s (NRG:TSX.V; NRGOF:OTC) focus is squarely on Nevada, where it acquired the high-grade Pamlico gold project in 2016. The company is in the ...
Streetwise Reports | November 15, 2019 |

Gold Sparkles as “The Great Lockdown” Hammers the Global Economy

Gold and gold stocks are among the highest performing assets of 2020 so far as investors seek a haven amid the coronavirus-fueled rout, and as central banks and governments around the world roll out unprecedented monetary and fiscal measures in an effort to mitigate the e...
Frank Holmes | April 14, 2020 |
1 2 3 4 5 6 7 8 9 10 ...